Last week, the World Health Assembly ? the decision-making body of the World Health Organization ? debated whether to obligate every country to donate at least .01% of its gross domestic product to R&D to combat these so-called neglected diseases. But the U.S., European Union and Japan opposed the idea. Instead, the assembly agreed to continue discussions and put forth new proposals next year. Why did Washington object? The Health Blog caught up with Nils Daulaire, director of the Office of Global Health Affairs at the Department of Health and Human Services and U.S. representative on the WHO?s Executive Board. He presented the U.S. position last week. In short: The U.S. supports the diagnosis, but not the prescription, Daulaire said.
Go here to see the original:?
Neglected Diseases ? How Should We Pay for R&D?
google april fools office space shell houston open ray allen mega millions winners anthony davis palm sunday
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.